Cargando…
Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NA...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323391/ https://www.ncbi.nlm.nih.gov/pubmed/34326098 http://dx.doi.org/10.1136/bmjgast-2021-000678 |
_version_ | 1783731232008306688 |
---|---|
author | Scragg, Jadine Hallsworth, Kate Taylor, Guy Cassidy, Sophie Haigh, Laura Boyle, Marie Anstee, Quentin McPherson, Stuart Avery, Leah |
author_facet | Scragg, Jadine Hallsworth, Kate Taylor, Guy Cassidy, Sophie Haigh, Laura Boyle, Marie Anstee, Quentin McPherson, Stuart Avery, Leah |
author_sort | Scragg, Jadine |
collection | PubMed |
description | OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NAFLD. DESIGN: 23 patients with NAFLD enrolled in a LED (~800 kcal/day) were individually interviewed. Transcripts were thematically analysed. RESULTS: 14/23 patients achieved ≥10% weight loss, 18/23 achieved ≥7% weight loss and 19/23 achieved ≥5% weight loss. Six themes were generated from the data. A desire to achieve rapid weight loss to improve liver health and prevent disease progression was the most salient facilitator to engagement. Early and significant weight loss, accountability to clinicians and regular appointments with personalised feedback were facilitators to engagement and adherence. The desire to receive positive reinforcement from a consultant was a frequently reported facilitator to adherence. Practical and emotional support from friends and family members was critically important outside of the clinical setting. Irregular working patterns preventing attendance at appointments was a barrier to adherence and completion of the intervention. CONCLUSIONS: Engagement and adherence to a LED in patients with NAFLD were encouraged by early and rapid weight loss, personalised feedback and positive reinforcement in the clinical setting combined with ongoing support from friends and family members. Findings support those identified in patients who completed a LED to achieve type 2 diabetes remission and highlight the importance of behaviour change support during the early stages of a LED to promote adherence. |
format | Online Article Text |
id | pubmed-8323391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-83233912021-08-19 Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease Scragg, Jadine Hallsworth, Kate Taylor, Guy Cassidy, Sophie Haigh, Laura Boyle, Marie Anstee, Quentin McPherson, Stuart Avery, Leah BMJ Open Gastroenterol Hepatology OBJECTIVE: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement and adherence to a low-energy diet (LED) as a treatment option for NAFLD. DESIGN: 23 patients with NAFLD enrolled in a LED (~800 kcal/day) were individually interviewed. Transcripts were thematically analysed. RESULTS: 14/23 patients achieved ≥10% weight loss, 18/23 achieved ≥7% weight loss and 19/23 achieved ≥5% weight loss. Six themes were generated from the data. A desire to achieve rapid weight loss to improve liver health and prevent disease progression was the most salient facilitator to engagement. Early and significant weight loss, accountability to clinicians and regular appointments with personalised feedback were facilitators to engagement and adherence. The desire to receive positive reinforcement from a consultant was a frequently reported facilitator to adherence. Practical and emotional support from friends and family members was critically important outside of the clinical setting. Irregular working patterns preventing attendance at appointments was a barrier to adherence and completion of the intervention. CONCLUSIONS: Engagement and adherence to a LED in patients with NAFLD were encouraged by early and rapid weight loss, personalised feedback and positive reinforcement in the clinical setting combined with ongoing support from friends and family members. Findings support those identified in patients who completed a LED to achieve type 2 diabetes remission and highlight the importance of behaviour change support during the early stages of a LED to promote adherence. BMJ Publishing Group 2021-07-29 /pmc/articles/PMC8323391/ /pubmed/34326098 http://dx.doi.org/10.1136/bmjgast-2021-000678 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Hepatology Scragg, Jadine Hallsworth, Kate Taylor, Guy Cassidy, Sophie Haigh, Laura Boyle, Marie Anstee, Quentin McPherson, Stuart Avery, Leah Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title_full | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title_fullStr | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title_full_unstemmed | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title_short | Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
title_sort | factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease |
topic | Hepatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323391/ https://www.ncbi.nlm.nih.gov/pubmed/34326098 http://dx.doi.org/10.1136/bmjgast-2021-000678 |
work_keys_str_mv | AT scraggjadine factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT hallsworthkate factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT taylorguy factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT cassidysophie factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT haighlaura factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT boylemarie factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT ansteequentin factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT mcphersonstuart factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease AT averyleah factorsassociatedwithengagementandadherencetoalowenergydiettopromote10weightlossinpatientswithclinicallysignificantnonalcoholicfattyliverdisease |